Barr Laboratories To Pay $225M In Class Settlement For Delaying Generic Cipro

Mealey's (February 1, 2017, 1:38 PM EST) -- SAN DIEGO — Six plaintiffs on Jan. 25 asked a state court to approve a $225 million settlement with Barr Laboratories Inc. for civil claims that the generic drug manufacturer caused consumers to pay higher prices when it took a cash payment from Bayer Corp. to not compete with Bayer Corp. by selling a generic version of the antibiotic Cipro (Cipro Cases I and II, JPPC Nos. 4154 and 4220, Calif. Super., San Diego Co.)....

Attached Documents

Related Sections